C12Y 207/11016
G-protein-coupled receptor kinase
Official title: G-Protein-coupled receptor kinase (2.7.11.16)
C12Y207/11016 (G-protein-coupled receptor kinase) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 8
- Assignees
- 6
- Inventors
- 26
- Latest grant
- 30 Mar 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 2 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Assays using arrestin recruitment and unmodified receptors30 Mar 2021US 10,962,538 B2The Trustees of Columbia University in the City of New York
- Method for treatment of diabetes by a small molecule inhibitor for GRK54 Oct 2016US 9,458,463 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Alpha-synuclein kinase3 Apr 2012US 8,148,089 B2Elan Pharma International Limited
- Alpha-synuclein kinase30 Jun 2009US 7,553,639 B2Elan Pharma International Limited
- Osteoarthritis progression inhibitor and progression inhibition kit7 Nov 2024US 2024/0366652 A1Kyushu University, National University Corporation
- Methods and compositions for treating cancer2 Feb 2023US 2023/0035892 A1Flagship Pioneering Innovations V, Inc.
- Assays using arrestin recruitment and unmodified receptors19 Dec 2019US 2019/0383808 A1The Trustees of Columbia University in the City of New York
- Kinases as targets for anti-diabetic therapy19 Mar 2015US 2015/0079108 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Kinases as targets for anti-diabetic therapy19 Dec 2013US 2013/0336986 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
Most cited
By later US patents